These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14979239)

  • 1. British Columbia poised to reduce drug coverage.
    Quandt T
    Can HIV AIDS Policy Law Rev; 2002 Mar; 6(3):38-9. PubMed ID: 14979239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.
    Anderson GM; Kerluke KJ; Pulcins IR; Hertzman C; Barer ML
    Inquiry; 1993; 30(2):199-207. PubMed ID: 8314608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using drugs to discriminate--adverse selection in the insurance marketplace.
    Jacobs DB; Sommers BD
    N Engl J Med; 2015 Jan; 372(5):399-402. PubMed ID: 25629737
    [No Abstract]   [Full Text] [Related]  

  • 4. The redistributive effect of the move from age-based to income-based prescription drug coverage in British Columbia, Canada.
    Hanley GE; Morgan S; Barer M; Reid RJ
    Health Policy; 2011 Jul; 101(2):185-94. PubMed ID: 21255859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada.
    Hanley GE; Morgan S; Hurley J; van Doorslaer E
    Health Econ; 2008 Dec; 17(12):1379-92. PubMed ID: 18189226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia.
    Grootendorst P; Stewart D
    Health Econ; 2006 Jul; 15(7):735-42. PubMed ID: 16498702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A first look at the new Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare Part D drug benefit and HIV/AIDS: questions and answers.
    Valenti WM
    AIDS Read; 2006 Feb; 16(2):66, 70-1. PubMed ID: 16471271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An outcomes-based approach to decisions about drug coverage policies in British Columbia.
    Morgan S; Bassett K; Mintzes B
    Psychiatr Serv; 2004 Nov; 55(11):1230-2. PubMed ID: 15534010
    [No Abstract]   [Full Text] [Related]  

  • 10. BC's Pharmacare speaks out.
    Tidball P
    Can Pharm J; 1980 Sep; 113(9):305-6, 316. PubMed ID: 10249552
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing prescription drug costs: a case study.
    DuBois RW; Feinberg PE
    Med Interface; 1994 Jun; 7(6):65-8, 70, 74. PubMed ID: 10135321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare prescription drug coverage: preparing for January 1, 2006.
    Crowley JS
    BETA; 2005; 17(4):34-41. PubMed ID: 16124121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences.
    Schneeweiss S; Maclure M; Dormuth CR; Glynn RJ; Canning C; Avorn J
    Clin Pharmacol Ther; 2006 Apr; 79(4):379-88. PubMed ID: 16580906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes-based drug coverage in British Columbia.
    Morgan S; Bassett K; Mintzes B
    Health Aff (Millwood); 2004; 23(3):269-76. PubMed ID: 15160825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective strategies for managing pharmacy benefits.
    Jacobson D
    Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-tiered-copayment drug coverage and use of nonsteroidal anti-inflammatory drugs.
    Briesacher B; Kamal-Bahl S; Hochberg M; Orwig D; Kahler KH
    Arch Intern Med; 2004 Aug 9-23; 164(15):1679-84. PubMed ID: 15302639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmaceutical industry's responsibilities in the prescription process.
    Tidball P
    Can Pharm J; 1981 May; 114(5):177-9. PubMed ID: 10251274
    [No Abstract]   [Full Text] [Related]  

  • 18. Using policy simulation to predict drug plan expenditure when planning reimbursement changes.
    Dormuth CR; Burnett S; Schneeweiss S
    Pharmacoeconomics; 2005; 23(10):1021-30. PubMed ID: 16235975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Employers push to manage prescription drug costs.
    Frieden J
    Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119
    [No Abstract]   [Full Text] [Related]  

  • 20. A prescription for a modern Medicare program.
    Bach PB; McClellan MB
    N Engl J Med; 2005 Dec; 353(26):2733-5. PubMed ID: 16382056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.